Unique ID issued by UMIN | UMIN000011551 |
---|---|
Receipt number | R000013514 |
Scientific Title | A prospective observational multicenter cohort study in patients with SFA lesions who underwent stenting in Kanagawa. |
Date of disclosure of the study information | 2013/08/23 |
Last modified on | 2014/02/24 10:18:42 |
A prospective observational multicenter cohort study in patients with SFA lesions who underwent stenting in Kanagawa.
KPTA1-Study
A prospective observational multicenter cohort study in patients with SFA lesions who underwent stenting in Kanagawa.
KPTA1-Study
Japan |
peripheral arterial disease
Cardiology |
Others
NO
The aims of the present study are to investigate prospectively the clinical course and outcome of the PAD patients with SFA lesions who underwent stenting in Kanagawa
Safety,Efficacy
Restenosis rate (1 year, 2 year)
TLR, MACLE (1 year, 2 year)
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patient criteria
Patients who meet all of the following criteria will be included in the study:
1. Chronic arteriosclerosis obliterans afflicting the SFA area*
(Rutherford classification 2-6)
*Except for patients with acute (within 1 week after onset)/subacute (2 weeks to 1 month after onset) lower limb ischemia
2. Age: 20 years or older at the time of consent
3. Gender: Male or female
4. Patients who can be monitored for at least 24 months after surgery
Lesion criteria
1. Superficial femoral artery stenosis or occlusive lesions.
2. At least 1 arterial runoff below the knee; stenosis lesions not limiting flow may be included.
In addition, patients with bilateral lesions or aorta-iliac artery lesions may be included.
3. Occlusive lesions may be included.
Patient criteria
Patients who meet any of the following criteria should be excluded from the study:
1.Patients with or at risk of hemorrhagic complications or patients with bleeding* tendency
*Bleeding such as hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis, or vitreous hemorrhage may be aggravated.
2.Pregnant or potentially pregnant women
3. Patients who are not eligible for the study in the opinion of the attending physician.
Lesion criteria
Lesions that meet any of the following criteria should be excluded from the study:
1.Remnant inflow (aorta-iliac artery lesion)
2.Severe calcification (lesions not expected to be appropriately expanded)
3.No arterial runoff below the knee
200
1st name | |
Middle name | |
Last name | Ichiro Michishita, / Akira Miyamoto |
Yokohama Sakae Kyosai Hospital / Kikuna Memorial Hospital
Cardiology / Cardiology
132 Katsura-cho Sakae-ku Yokohama, Japan / 4-4-27 Kikuna Kohoku-ku Yokohama, Japan
045-402-7111
qqfw76rd@bell.ocn.ne.jp
1st name | |
Middle name | |
Last name | Yasutaka Yamauchi |
Kikuna Memorial Hospital
Cardiology
4-4-27 Kikuna Kohoku-ku Yokohama, Japan
045-402-7111
qqfw76rd@bell.ocn.ne.jp
Kikuna Memorial Hospital
None
Self funding
NO
2013 | Year | 08 | Month | 23 | Day |
Unpublished
Open public recruiting
2013 | Year | 08 | Month | 21 | Day |
2014 | Year | 01 | Month | 01 | Day |
patient's background, ischemia, ABPI, Echo, laboratory test, device, antiplatelet therapy
2013 | Year | 08 | Month | 22 | Day |
2014 | Year | 02 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013514